CYCN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cyclerion Therapeutics Inc (CYCN) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are bearish, there are no significant trading trends or positive news catalysts, and the stock lacks recent AI Stock Picker or SwingMax signals. While financial performance shows improvement in revenue and net income, the company is still unprofitable, and no significant analyst or institutional sentiment supports the stock. The investor should wait for clearer positive signals or catalysts before considering an investment.
The technical indicators are bearish. The MACD is below 0 and negatively contracting, RSI is neutral at 43.73, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 1.255, with key support at 1.066 and resistance at 1.443.
Revenue increased by 351.03% YoY in Q3 2025, and net income improved by 34.99% YoY. Gross margin remains at 100%.
There are no recent news catalysts, no significant insider or hedge fund trading trends, and no recent congress trading data. Technical indicators are bearish, and the stock lacks momentum.
In Q3 2025, revenue increased significantly to $875,000 (up 351.03% YoY), net income improved to -$976,000 (up 34.99% YoY), and EPS increased to -0.3 (up 3.45% YoY). Gross margin remains at 100%. Despite improvements, the company is still operating at a loss.
No analyst rating or price target changes available.
